Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States

Psychedelic States and Schizophrenia

As long as a man can talk to himself about himself, he retains some sense of personal identity and separateness. Once he stops talking (self-reflective thinking) and begins to listen "to the song going on within him," all boundaries, internal and external, cease to exist—including the internal-external boundary itself. In some cases, this state is experienced or interpreted as psychotic death; ...

Over 30 million psychedelic users in the United States

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of...

Enhanced repertoire of brain dynamical states during the psychedelic experience.

The study of rapid changes in brain dynamics and functional connectivity (FC) is of increasing interest in neuroimaging. Brain states departing from normal waking consciousness are expected to be accompanied by alterations in the aforementioned dynamics. In particular, the psychedelic experience produced by psilocybin (a substance found in "magic mushrooms") is characterized by unconstrained co...

Psychotoxic or Psychedelic

Therapeutic potential of psychedelic agents

Amphetamine, methylphenidate, morphine, heroin and ketamine are all drugs that can potentially be used clinically but, whenever we hear the word MDMA, the first thoughts that come to mind are of ecstasy, rave parties and people behaving in an odd manner and experiencing hallucinations, paranoia and disinhibition. Recently, there has been a lot of discussion on the use of MDMA for treatment-resi...